851B

DRUG2 trials

Sponsors

Takeda

Conditions

Papillomavirus Infections

Phase 2

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

TerminatedNCT00117884

TakedaPapillomavirus Infections

Start: 2006-04-30End: 2008-06-30Updated: 2016-08-19

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

TerminatedNCT00312286

TakedaPapillomavirus Infections

Start: 2006-04-30End: 2008-06-30Updated: 2016-09-23